BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16460951)

  • 21. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields.
    Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B
    Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT.
    Shirakawa M; Yamamto T; Nakai K; Aburai K; Kawatobi S; Tsurubuchi T; Yamamoto Y; Yokoyama Y; Okuno H; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S88-90. PubMed ID: 19446462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
    Wittig A; Collette L; Moss R; Sauerwein WA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
    Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
    Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel method for boronating antibodies without loss of immunoreactivity, for use in neutron capture therapy.
    Ferro VA; Morris JH; Stimson WH
    Drug Des Discov; 1995 Aug; 13(1):13-25. PubMed ID: 8882898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
    Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
    Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
    Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
    Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
    Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Tjarks W; Lorey DR; Barth RF
    J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological evaluation of dopamine analogues containing phenylboronic acid group as new boron carriers.
    Ito Y; Mizuno T; Yoshino K; Ban HS; Nakamura H; Hiratsuka J; Ishikawa A; Ohki H
    Appl Radiat Isot; 2011 Dec; 69(12):1771-3. PubMed ID: 21543232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
    Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1339-43. PubMed ID: 24508130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.